Shedding light on developmental drugs for idiopathic pulmonary fibrosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Shedding light on developmental drugs for idiopathic pulmonary fibrosis
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2020-06-13
DOI
10.1080/13543784.2020.1782885
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models
- (2020) Jos L. van der Velden et al. PLoS One
- A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase 1 Study of Aerosolized Pirfenidone Delivered via the PARI Investigational eFlow Nebulizer in Volunteers and Patients with Idiopathic Pulmonary Fibrosis
- (2019) Jun Keng Khoo et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
- (2019) Ganesh Raghu et al. Lancet Respiratory Medicine
- Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Luca Richeldi et al. Lancet Respiratory Medicine
- A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors
- (2018) Lyne Gagnon et al. AMERICAN JOURNAL OF PATHOLOGY
- Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial
- (2018) Carlo Vancheri et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis
- (2018) Rachel S. Knipe et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- OPTN/SRTR 2016 Annual Data Report: Lung
- (2018) M. Valapour et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Safety of Nintedanib Added to Pirfenidone Treatment for Idiopathic Pulmonary Fibrosis
- (2018) Kevin R. Flaherty et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
- (2018) Ganesh Raghu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review
- (2018) Alex Diamantopoulos et al. PHARMACOECONOMICS
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
- (2018) Toby M Maher et al. Lancet Respiratory Medicine
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis
- (2018) Nasreen Khalil et al. EUROPEAN RESPIRATORY JOURNAL
- Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis
- (2017) Fu Jun Li et al. JOURNAL OF IMMUNOLOGY
- Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis
- (2017) Sebastian Bickelhaupt et al. JNCI-Journal of the National Cancer Institute
- Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
- (2017) Ana L. Mora et al. NATURE REVIEWS DRUG DISCOVERY
- Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions
- (2017) Jonathan A. Galli et al. RESPIROLOGY
- Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis
- (2017) Sebastian Bickelhaupt et al. JNCI-Journal of the National Cancer Institute
- Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities
- (2016) Jennifer E. Ho et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Type V Collagen in Health, Disease, and Fibrosis
- (2016) Ki M. Mak et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis
- (2016) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy
- (2016) Bernt van den Blink et al. EUROPEAN RESPIRATORY JOURNAL
- Association Between Interstitial Lung Abnormalities and All-Cause Mortality
- (2016) Rachel K. Putman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
- (2016) Paolo Spagnolo et al. JOURNAL OF MEDICAL GENETICS
- Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
- (2016) Martin Kolb et al. THORAX
- Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Jürgen Behr et al. Lancet Respiratory Medicine
- Idiopathic pulmonary fibrosis: An update
- (2015) Paolo Spagnolo et al. ANNALS OF MEDICINE
- Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis
- (2015) David S. Wilkes et al. EUROPEAN RESPIRATORY JOURNAL
- A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
- (2015) Harold R. Collard et al. EUROPEAN RESPIRATORY JOURNAL
- Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
- (2015) John Hutchinson et al. EUROPEAN RESPIRATORY JOURNAL
- Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
- (2015) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis
- (2015) Antoine François et al. JOURNAL OF AUTOIMMUNITY
- An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode
- (2015) Andrea Doni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis. An Integral Model
- (2014) Moisés Selman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
- (2014) Takashi Ogura et al. EUROPEAN RESPIRATORY JOURNAL
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
- (2014) Daryle J DePianto et al. THORAX
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
- (2014) Ganesh Raghu et al. Lancet Respiratory Medicine
- Pathogenesis of Idiopathic Pulmonary Fibrosis
- (2013) Paul J. Wolters et al. Annual Review of Pathology-Mechanisms of Disease
- Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
- (2013) Yong Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities
- (2013) Gary M. Hunninghake et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis
- (2013) Ragini Vittal et al. PLoS One
- Interstitial Lung Abnormalities in a CT Lung Cancer Screening Population: Prevalence and Progression Rate
- (2013) Gong Yong Jin et al. RADIOLOGY
- Rituximab in severe, treatment-refractory interstitial lung disease
- (2013) Gregory J. Keir et al. RESPIROLOGY
- Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2012) Nikos Oikonomou et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The telomere syndromes
- (2012) Mary Armanios et al. NATURE REVIEWS GENETICS
- Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
- (2011) Alison C. MacKinnon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
- (2011) Masato Kono et al. CLINICA CHIMICA ACTA
- Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
- (2011) George R. Washko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- LPA Receptors: Subtypes and Biological Actions
- (2010) Ji Woong Choi et al. Annual Review of Pharmacology and Toxicology
- Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages
- (2010) Lynne A. Murray et al. PLoS One
- Lysophosphatidic Acid Induces αvβ6 Integrin-Mediated TGF-β Activation via the LPA2 Receptor and the Small G Protein Gαq
- (2009) Ming Yan Xu et al. AMERICAN JOURNAL OF PATHOLOGY
- The regulation of inflammation by galectin-3
- (2009) Neil C. Henderson et al. IMMUNOLOGICAL REVIEWS
- Serum Amyloid P Inhibits Fibrosis Through Fc R-Dependent Monocyte-Macrophage Regulation in Vivo
- (2009) A. P. Castano et al. Science Translational Medicine
- c-Jun N-Terminal Kinase 1 Is Required for the Development of Pulmonary Fibrosis
- (2008) John F. Alcorn et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Applications for ROCK kinase inhibition
- (2008) Michael F Olson CURRENT OPINION IN CELL BIOLOGY
- Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF- 1
- (2008) J. F. Alcorn et al. JOURNAL OF CELL SCIENCE
- JNK signaling in apoptosis
- (2008) D N Dhanasekaran et al. ONCOGENE
- Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis
- (2007) Khalid Puthawala et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started